KNTE
Kinnate Biopharma Inc. Common Stock
KNTE
KNTE
Delisted
KNTE was delisted on the 2nd of April, 2024.
79 hedge funds and large institutions have $249M invested in Kinnate Biopharma Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 23 increasing their positions, 26 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
79
Holders Change
-5
Holders Change %
-5.95%
% of All Funds
1.27%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.08%
New
10
Increased
23
Reduced
26
Closed
13
Calls
$1K
Puts
$1K
Net Calls
–
Net Calls Change
-$569K
Top Buyers
1 |
LCM
Lynx1 Capital Management
San Juan,
Puerto Rico
|
$12.2M |
2 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
$825K |
3 |
BlackRock
New York
|
$14.2M |
4 |
XT
XTX Topco
George Town,
Cayman Islands
|
$237K |
5 |
Squarepoint
New York
|
$153K |